Delivery Order SPE2DB22D3301-SPE2DB24FZ4MB

Award Date 9/16/24
Potential Completion Date 10/7/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $15,346.55 contract is for the supply of CABOMETYX 40 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,908.27 firm-fixed-price contract is for the supply of CABOMETYX 60 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and was awarded on October 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 40 MG TABLET 30S, a medication. The contract has a ceiling value of $15,346.55 and a period of performance through July 24, 2025. The contract is a Firm Fixed Price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $15,346.55 and a completion date of June 27, 2025. It is a firm fixed-price contract and is not set-aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
This is a $15,346.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 40 MG TABLET 30S medication, with a performance period through July 15, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Cabometyx 60 mg tablets. The contract has a ceiling value of $30,602.10 and a period of performance through May 29, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,867.18 firm-fixed-price award is for the supply of CABOMETYX 40 MG TABLET 30S, a prescription pharmaceutical product. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,346.55 and a period of performance through July 28, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract has a firm fixed price of $15,346.55 and a period of performance through June 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cabometyx 60 mg tablets. The contract has a firm fixed price of $15,301.05 and a period of performance through May 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ4MB
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $27,816.56 and a period of performance ending on October 7, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and supplies, to support military treatment programs and facilities worldwide.

Generated 12/16/24, 2:03 PM